Table 1.
Patient demographics: IgAN versus healthy controls
| Demographic | IgANa | Healthy Controlsa | Pb |
|---|---|---|---|
| Age (years) | 38.0 ± 10.2 | 29.9 ± 10.4 | 0.05 |
| Gender (male/female) | 12/10 | 5/5 | 0.82 |
| Height (cm) | 170.0 ± 11.3 | 169.4 ± 10.2 | 0.85 |
| Mean systolic BP (mmHg) | 131.5 ± 9.8 | 117.1 ± 1 | 0.03 |
| Mean diastolic BP (mmHg) | 79.0 ± 13.2 | 73.6 ± 5.9 | 0.16 |
| Serum creatinine (mg/dl) | 1.0 ± 0.31 | 0.94 ± 0.18 | 0.02 |
| GFR (ml/min per 1.73 m2) | 72.0 ± 21.7 | 108.2 ± 12.6 | <0.01 |
| ΔGFR (ml/min per 1.73 m2 per year) | −5.0 ± 12.0 | NA | NA |
| Proteinuria (g/day) | 2.0 ± 2.05 | NA | NA |
IgAN, IgA nephropathy; NA, not available.
a
Mean values are presented as mean ± SD. Other values are presented as the number of patients.
b
P values are calculated to evaluate whether there is any significant difference between the two groups.